8 reports

Top ## players hold majority of stake in the market ##.

  • Insulin
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.

TRAVEL AND ENDEMIC VACCINES COMPRISE AN ARRAY OF PRODUCTS THAT OFFERS PROTECTION FROM HEPATITIS A, TYPHOID, RABIES, YELLOW FEVER, JAPANESE ENCEPHALITIS, CHOLERA, MMR AND VENOMS.

  • Insulin
  • United States
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Takeda Pharmaceutical Company Limited
  • HIGHLIGHTS THE DISTRIBUTION OF THE NOVEL NON-INSULIN ANTI-DIABETIC DRUGS BASED UPON THEIR CURRENT DEVELOPMENT STATUS.
  • 9. NOVEL NON-INSULIN THERAPIES FOR DIABETES

STUDIES IN ANIMAL MODELS DEMONSTRATED A DECREASE IN AUTOIMMUNE ENCEPHALITIS DUE TO THE PRODUCTION OF LAP EXPRESSING T CELLS.

  • Insulin
  • North America
  • United States
  • Boehringer Ingelheim GmbH
  • Sanofi S.A.

The company offers products in the therapeutic areas of stroke, encephalopathies, craniocerebral trauma, encephalitis, autonomic neuropathy, ophthalmology, endocrinology and epilepsy, among others.

  • Cell Therapy
  • Insulin
  • United States
  • Company
  • Product Initiative
  • TYPE 1 DIABETES (JUVENILE DIABETES) - PIPELINE BY GEROPHARM LLC, H2 2017

In the experimental autoimmune encephalitis mouse model of MS, short term treatments with CGEN-## resulted in a long term dramatic improvement of disease symptoms.

  • Chronic Disease
  • Insulin
  • United States
  • World
  • Company
  • TYPE2 DIABETES - PIPELINE BY GEROPHARM LLC, H1 2018

The company offers products in the therapeutic areas of stroke, encephalopathies, craniocerebral trauma, encephalitis, autonomic neuropathy, ophthalmology, endocrinology and epilepsy, among others.

  • Biopharmaceutical
  • Insulin
  • North America
  • United States
  • Company
  • GMC-278

The company offers products in the therapeutic areas of stroke, encephalopathies, craniocerebral trauma, encephalitis, autonomic neuropathy, ophthalmology, endocrinology, epilepsy and others.

  • Biopharmaceutical
  • Insulin
  • North America
  • United States
  • Company

In the experimental autoimmune encephalitis mouse model of MS, short term treatments with CGEN-## resulted in a long term dramatic improvement of disease symptoms.

  • Insulin
  • Research And Development
  • United States
  • Product Initiative
  • Novo Nordisk Group